» Articles » PMID: 23171086

Connecting the Chemical and Biological Reactivity of Epoxides

Overview
Specialty Toxicology
Date 2012 Nov 23
PMID 23171086
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The chemical reactivity of the mutagenic epoxides (EP) propylene oxide (PO), 1,2-epoxybutane (1,2-EB), and cis- and trans-2,3-epoxybutane (cis- and trans-2,3-EB) with 4-(p-nitrobenzyl)pyridine (NBP), a bionucleophile model for S(N)2 alkylating agents with high affinity for the guanine-N7 position, was investigated kinetically. It was found that three reactions are involved simultaneously: the alkylation reaction of NBP by EP, which yields the corresponding NBP-EP adducts through an S(N)2 mechanism, and EP and NBP-EP hydrolysis reactions. PO and 1,2-EB were seen to exhibit a higher alkylating potential than cis- and trans-2,3-EB. From a study of the correlations between the chemical reactivity (kinetic parameters) and the biological effectiveness of oxiranes, the following conclusions can be drawn: (i) the hydrolysis reactions of epoxides must be taken into account to understand their bioactivity. (ii) The fraction (f) of the alkylating oxirane that forms the adduct and the adduct life (AL) permit the potential of epoxides as bioactive molecules to be rationalized even semiquantitatively; and (iii) alkylation of DNA by epoxides and the O(6)-/N7-guanine adduct ratio are directly related to their mutagenicity in vitro.

Citing Articles

Glycidamide-induced hypermutation in yeast single-stranded DNA reveals a ubiquitous clock-like mutational motif in humans.

Hudson K, Klimczak L, Sterling J, Burkholder A, Kazanov M, Saini N Nucleic Acids Res. 2023; 51(17):9075-9100.

PMID: 37471042 PMC: 10516655. DOI: 10.1093/nar/gkad611.


Enlightening the Path to Protein Engineering: Chemoselective Turn-On Probes for High-Throughput Screening of Enzymatic Activity.

Hecko S, Schiefer A, Badenhorst C, Fink M, Mihovilovic M, Bornscheuer U Chem Rev. 2023; 123(6):2832-2901.

PMID: 36853077 PMC: 10037340. DOI: 10.1021/acs.chemrev.2c00304.


Design and Synthesis of 1,2-Deoxy-pyranose Derivatives of Spliceostatin A toward Prostate Cancer Treatment.

Yoshikawa Y, Ishibashi A, Takehara T, Suzuki T, Murai K, Kaneda Y ACS Med Chem Lett. 2020; 11(6):1310-1315.

PMID: 32551017 PMC: 7294732. DOI: 10.1021/acsmedchemlett.0c00153.


Stabilized cyclopropane analogs of the splicing inhibitor FD-895.

Villa R, Kashyap M, Kumar D, Kipps T, Castro J, La Clair J J Med Chem. 2013; 56(17):6576-82.

PMID: 23919277 PMC: 3809018. DOI: 10.1021/jm400861t.